Evidence map›Paper›PMID 20216169›Full record

SynthesisPediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies2010

Neonatal pulmonary hypertension.

Robin H Steinhorn

Registry-linked trialOpen access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07322133 (Dopamine vs. Norepinephrine in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure and Systemic Hypotension Due to Pulmonary Hypertension), which is not on this map. Cited by 89 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 3 pooled it
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07322133 phase4recruitingnot on this mapstarted 2026, after this paper: background citation

Dopamine vs. Norepinephrine in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure and Systemic Hypotension Due to Pulmonary Hypertension: A Pilot Trial

TypeinterventionalSponsorUniversity of California, DavisRan2026 to 2027Enrolled30ConditionsHypotension and Shock, Pulmonary Hypertension of the Newborn (PPHN), Hypoxemic Respiratory FailureArmsDopamine administration, Norepinephrine
3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 3 syntheses or guidelines pooled it, 211 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Methods for establishing animal models of persistent pulmonary hypertension of the newborn: A systematic literature analysis.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
    Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Association between vasoactive-inotropic score, clinical outcomes, defect size and laterality in congenital diaphragmatic hernia.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. ExploringDiagnostics (Basel, Switzerland) · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. A Natural History Study of Timothy Syndrome.Orphanet journal of rare diseases · 2024
    Article
  18. Review
  19. Review
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Robin H SteinhornDivision of Neonatology, Children's Memorial Hospital, Northwestern University's Feinberg School of Medicine, Chicago, IL, USA. r-steinhorn@northwestern.edu
Northwestern Memorial Hospital · US

Funding

REDOX REGULATION IN THE PERINATAL PULMONARY VASCULATURER01HL054705 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI STEINHORN, ROBIN H. · 2001 to 2013
$4.8M
CGMP REGULATION IN THE DEVELOPING PULMONARY VASCULATURER29HL054705 · NHLBI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI STEINHORN, ROBIN H · 1995 to 1998
–
NHLBI NIH HHS HL54705NHLBI NIH HHS R01 HL054705NHLBI NIH HHS R29 HL054705
6 · The paper itself

Abstract

When the normal cardiopulmonary transition fails to occur, the result is persistent pulmonary hypertension of the newborn. Severe persistent pulmonary hypertension of the newborn is estimated to occur in 2 per 1000 live-born term infants, and some degree of pulmonary hypertension complicates the course of >10% of all neonates with respiratory failure. This review article discusses the vascular abnormalities that are associated with neonatal pulmonary hypertension, including recognition of its role in severe bronchopulmonary dysplasia in preterm infants. A systematic review of the evidence for common therapies including inhaled nitric oxide, high-frequency ventilation, surfactant, and extracorporeal life support is included. Finally, this field is rapidly evolving, and the rationale for promising new treatment approaches is reviewed, including inhibition of phosphodiesterases and scavengers of reactive oxygen species.

Indexed as

Administration, InhalationBronchopulmonary DysplasiaExtracorporeal Membrane OxygenationHigh-Frequency VentilationHumansHypertension, PulmonaryInfant, NewbornNitric OxidePulmonary SurfactantsNitric OxidePulmonary Surfactants

Identifiers

PMID20216169
PMCPMC2843001
OpenAlexW2139737196

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.